Review Article
Contralateral Risk-Reducing Mastectomy: Review of Risk Factors and Risk-Reducing Strategies
Table 1
Risk factors for developing CBC (estimated annual risk) [
4,
7].
| | Estimated annual risk (%) [4] | Relative risk—multivariate (95% CI) [7] |
| Patient factors | | | Age at first diagnosis | | | <30 yrs | 0.5–1.3 | | 40–50 yrs | | | ER +ve | 0.2-0.3 | | ER −ve | 0.4-0.5 | | Gene mutation | | | BRCA1 | 2.0–3.0 | | BRCA2 | 2.0–3.0 | | Family history | | | None | | 1 (reference) | First- and second-degree | 0.4–1.3 | 2.8 (1.4–5.5) | First-degree | 0.2–0.8 | 1.4 (0.9–2.1) | Second- or third-degree | Baseline | 1.1 (0.7–1.9) | Tumour factors | | | Size | | | <2 cm (T1) | | 1 (reference) | 2–5 cm (T2) | | 1.5 (1.1–2.0) | >5 cm (T3) | | 1.9 (1.1–3.3) | LN status | | | None | | 1 (reference) | 1–3 | | 0.9 (0.6–1.2) | 4–9 | | 1.1 (0.7–1.9) | >10 | | 1.6 (0.8–3.1) | Histology | | | Ductal | | 1 (reference) | Lobular | | 1.2 (0.6–2.1) | ER status | | | ER positive | | 1.0 (reference) | ER negative | | 1.3 (0.9–1.9) | HER2 status | | | HER2 positive | | 1.0 (reference) | HER2 negative | | 1.02 (0.6–1.8) |
|
|